Top

Published in:

Open Access 01-12-2011 | Research article

Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial

Authors: Erik Andersson, Brjánn Ljótsson, Filip Smit, Björn Paxling, Erik Hedman, Nils Lindefors, Gerhard Andersson, Christian Rück

Published in: BMC Public Health | Issue 1/2011

Abstract

Background

Irritable Bowel Syndrome (IBS) is highly prevalent and is associated with a substantial economic burden. Cognitive behavior therapy (CBT) has been shown to be effective in treating IBS. The aim of this study was to evaluate the cost-effectiveness of a new treatment alternative, internet-delivered CBT based on exposure and mindfulness exercises.

Methods

Participants (N = 85) with IBS were recruited through self-referral and were assessed via a telephone interview and self-report measures on the internet. Participants were randomized to internet-delivered CBT or to a discussion forum. Economic data was assessed at pre-, post- and at 3-month and 1 year follow-up.

Results

Significant cost reductions were found for the treatment group at $16,806 per successfully treated case. The cost reductions were mainly driven by reduced work loss in the treatment group. Results were sustained at 3-month and 1 year follow-up.

Conclusions

Internet-delivered CBT appears to generate health gains in IBS treatment and is associated with cost-savings from a societal perspective.

Available only for authorised users

Lacy BE, Lee RD: Irritable bowel syndrome: a syndrome in evolution. J Clin Gastroenterol. 2005, 39 (5 Suppl 3): S230-42. 10.1097/01.mcg.0000156110.69232.bb.CrossRefPubMed

Drossman DA, et al: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993, 38 (9): 1569-80. 10.1007/BF01303162.CrossRefPubMed

Hillila MT, Farkkila NJ, Farkkila MA: Societal costs for irritable bowel syndrome--a population based study. Scand J Gastroenterol. 2010, 45 (5): 582-91. 10.3109/00365521003637211.CrossRefPubMed

Nyrop KA, et al: Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007, 26 (2): 237-48. 10.1111/j.1365-2036.2007.03370.x.CrossRefPubMed

Ford AC, et al: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009, 58 (3): 367-78. 10.1136/gut.2008.163162.CrossRefPubMed

Creed F, et al: The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003, 124 (2): 303-17. 10.1053/gast.2003.50055.CrossRefPubMed

McCrone P, et al: Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2008, 20 (4): 255-63. 10.1097/MEG.0b013e3282f2519d.CrossRefPubMed

Ljotsson B, et al: Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behav Res Ther. 48 (6): 531-9. 10.1016/j.brat.2010.03.003.

Lackner JM, et al: Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol. 2008, 6 (8): 899-906. 10.1016/j.cgh.2008.03.004.CrossRefPubMedPubMedCentral

10.

Andersson G: Using the Internet to provide cognitive behaviour therapy. Behav Res Ther. 2009, 47 (3): 175-80. 10.1016/j.brat.2009.01.010.CrossRefPubMed

11.

Spek V, et al: Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med. 2007, 37 (3): 319-28. 10.1017/S0033291706008944.CrossRefPubMed

12.

Griffiths F, et al: Why are health care interventions delivered over the internet? A systematic review of the published literature. J Med Internet Res. 2006, 8 (2): e10-10.2196/jmir.8.2.e10.CrossRefPubMedPubMedCentral

13.

Longstreth GF, et al: Functional bowel disorders. Gastroenterology. 2006, 130 (5): 1480-91. 10.1053/j.gastro.2005.11.061.CrossRefPubMed

14.

Svanborg P, Åsberg M: A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 1994, 89 (1): 21-8. 10.1111/j.1600-0447.1994.tb01480.x.CrossRefPubMed

15.

Saunders JB, et al: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993, 88 (6): 791-804. 10.1111/j.1360-0443.1993.tb02093.x.CrossRefPubMed

16.

Berman AH, et al: Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005, 11 (1): 22-31. 10.1159/000081413.CrossRefPubMed

17.

Sheehan DV, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59 (Suppl 20): 22-33. quiz 34-57PubMed

18.

Ljotsson B, et al: Exposure and mindfulness based therapy for irritable bowel syndrome - An open pilot study. J Behav Ther Exp Psychiatry. 2010

19.

Svedlund J, Sjodin I, Dotevall G: GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988, 33 (2): 129-34. 10.1007/BF01535722.CrossRefPubMed

20.

Blanchard EB: Irritable bowel syndrome: Psychosocial assessment and treatment. xi. 2001, Washington, DC, US: American Psychological Association, 1-373.CrossRef

21.

Hakkaart-Van Roijen L, Donker M: Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P). 2002

22.

Drummond MF, et al: Methods for the economic evaluation of health care programmes. 2005, Oxford: Oxford University Press, Third

23.

Smit F, et al: Cost-effectiveness of preventing depression in primary care patients: randomised trial. Br J Psychiatry. 2006, 188: 330-6. 10.1192/bjp.188.4.330.CrossRefPubMed

24.

Organisation for economic co-operation and development. 2008, [http://www.oecd.org]

25.

Efron B, Tibshirani RJ: An introduction to the bootstrap. 1993, New York: Chapman & HallCrossRef

26.

Long JS, Freese J: Regression models for categorical dependent variables using Stata. 2006, College Station, Tex.: StataCorp LP, xxv-527, 2

27.

Kennedy T, et al: Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ. 2005, 331 (7514): 435-10.1136/bmj.38545.505764.06.CrossRefPubMedPubMedCentral

28.

Patel A, et al: A comparison of two methods of collecting economic data in primary care. Fam Pract. 2005, 22 (3): 323-327. 10.1093/fampra/cmi027.CrossRefPubMed

29.

Hakkaart-van Roijen L, et al: Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007, 16 (5): 316-26. 10.1007/s00787-007-0603-6.CrossRefPubMed

30.

van der Feltz-Cornelis CM, et al: Randomised controlled trial of a psychiatric consultation model for treatment of common mental disorder in the occupational health setting. BMC Health Serv Res. 2007, 7: 29-10.1186/1472-6963-7-29.CrossRefPubMedPubMedCentral

31.

Horn EK, et al: Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial. BMC Health Serv Res. 2007, 7: 28-10.1186/1472-6963-7-28.CrossRefPubMedPubMedCentral

32.

Mangel AW, et al: Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res. 1998, 26 (2): 76-81.PubMed

33.

Camilleri M, et al: Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000, 355 (9209): 1035-40. 10.1016/S0140-6736(00)02033-X.CrossRefPubMed

34.

Francis CY, Morris J, Whorwell PJ: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997, 11 (2): 395-402. 10.1046/j.1365-2036.1997.142318000.x.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/11/215/prepub

Title: Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial
Authors: Erik Andersson
Brjánn Ljótsson
Filip Smit
Björn Paxling
Erik Hedman
Nils Lindefors
Gerhard Andersson
Christian Rück
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/1471-2458-11-215

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Higher body mass index may induce asthma among adolescents with pre-asthmatic symptoms: a prospective cohort study

Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women

Dietary patterns and hypertension among Chinese adults: a nationally representative cross-sectional study

Are risk estimates biased in follow-up studies of psychosocial factors with low base-line participation?

"Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"

A step forward for understanding the morbidity burden in Guinea: a national descriptive study